A detailed history of Fernwood Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 12,690 shares of ABBV stock, worth $2.25 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
12,690
Previous 12,960 2.08%
Holding current value
$2.25 Million
Previous $2.22 Million 12.78%
% of portfolio
0.83%
Previous 0.7%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $44,236 - $53,819
-270 Reduced 2.08%
12,690 $2.51 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $179,401 - $209,500
-1,159 Reduced 8.21%
12,960 $2.22 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $96,531 - $109,988
-604 Reduced 4.1%
14,119 $2.57 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.01%
14,723 $2.28 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $133 - $154
1 Added 0.01%
14,721 $2.19 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $174,648 - $217,338
1,318 Added 9.83%
14,720 $1.98 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $144,176 - $166,040
997 Added 8.04%
13,402 $2.14 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $138 - $165
1 Added 0.01%
12,405 $2.01 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $81,197 - $93,127
-605 Reduced 4.65%
12,404 $1.67 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $244,825 - $311,253
-1,779 Reduced 12.03%
13,009 $1.99 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $115,086 - $142,790
-872 Reduced 5.57%
14,788 $2.4 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $53,070 - $67,149
494 Added 3.26%
15,660 $2.12 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $21,386 - $24,276
201 Added 1.34%
15,166 $1.64 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $109,944 - $122,484
1,045 Added 7.51%
14,965 $1.69 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $28,132 - $30,970
-275 Reduced 1.94%
13,920 $1.51 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $8,048 - $10,867
100 Added 0.71%
14,195 $1.52 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $42,955 - $50,415
500 Added 3.68%
14,095 $1.24 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $14,674 - $19,636
200 Added 1.49%
13,595 $1.34 Million
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $11,932 - $18,091
-185 Reduced 1.36%
13,395 $1.02 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $7,213 - $9,025
-100 Reduced 0.73%
13,580 $1.2 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $94,470 - $113,580
-1,500 Reduced 9.88%
13,680 $1.04 Million
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $8,212 - $10,497
-125 Reduced 0.82%
15,180 $1.1 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $7,784 - $9,601
-100 Reduced 0.65%
15,305 $1.41 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $35,564 - $39,536
-400 Reduced 2.53%
15,405 $1.46 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $17,956 - $21,246
-200 Reduced 1.25%
15,805 $1.46 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $138,015 - $184,815
-1,500 Reduced 8.57%
16,005 $1.52 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $1.22 Million - $1.56 Million
17,505
17,505 $1.56 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fernwood Investment Management, LLC Portfolio

Follow Fernwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.